During the initial indolent chronic phase of chronic myeloid leukemia (CML), the t(9;22)(q34;q11), resulting in the Philadelphia chromosome (Ph), is usually the sole cytogenetic anomaly, but as the disease progresses into the accelerated phase (AP), and eventually into aggressive blast crisis (BC), secondary aberrations, mainly unbalanced changes such as +8, i(17q), and +Ph, are frequent. To date, molecular genetic studies of CML BC have mainly focused on alterations of well-known tumor-suppressor genes (e.g., TP53, CDKN2A, and RB1) and oncogenes (e.g., RAS and MYC), whereas limited knowledge is available about the molecular genetic correlates of the unbalanced chromosomal abnormalities. Balanced secondary changes are rare in CML AP/BC, but...
At diagnosis, about 5% of Chronic Myeloid Leukemia (CML) patients lacks Philadelphia chromosome (Ph)...
Chronic myelogenous leukemia (CML) in accelerated phase (AP-CML). Epidemiology Only one case to date...
Complex variant 9;22 translocations occur in a significant minority of chronic myelogenous leukaemia...
The t(9;22)(q34;q11) is evident in more than 90% of patients with chronic myelocytic leukemia (CML) ...
The t(9;22)(q34;q11) is evident in more than 90% of patients with chronic myelocytic leukemia (CML) ...
Chronic myelogenous leukemia(CML)is characterized by the presence of the abnormal chromosome 22, whi...
Fluorescence in situ hybridization (FISH) has become an increasingly important method for assessing ...
We describe two novel chromosomal translocations in two cases of leukemia in which these translocati...
Abstract Background Chronic myeloid leukaemia (CML) is a haematopoietic stem cell disorder, almost a...
Background : Chronic myelogenous leukemia (CML) is characterised by the t(9;22)(q34;q11.2) which res...
We describe the application of fluorescence in situ hybridization (FISH) in a case of suspected chro...
Abstract Background The t(9;22)(q34;q11), generating the Philadelphia (Ph) chromosome, is found in m...
The virtually obligatory presence of the Philadelphia chromosome may suggest a causal homogeneity, b...
Background/Aims: New molecular cytogenetic tech-niques are increasingly applied as a routine investi...
At diagnosis, about 5% of Chronic Myeloid Leukemia (CML) patients lacks Philadelphia chromosome (Ph)...
At diagnosis, about 5% of Chronic Myeloid Leukemia (CML) patients lacks Philadelphia chromosome (Ph)...
Chronic myelogenous leukemia (CML) in accelerated phase (AP-CML). Epidemiology Only one case to date...
Complex variant 9;22 translocations occur in a significant minority of chronic myelogenous leukaemia...
The t(9;22)(q34;q11) is evident in more than 90% of patients with chronic myelocytic leukemia (CML) ...
The t(9;22)(q34;q11) is evident in more than 90% of patients with chronic myelocytic leukemia (CML) ...
Chronic myelogenous leukemia(CML)is characterized by the presence of the abnormal chromosome 22, whi...
Fluorescence in situ hybridization (FISH) has become an increasingly important method for assessing ...
We describe two novel chromosomal translocations in two cases of leukemia in which these translocati...
Abstract Background Chronic myeloid leukaemia (CML) is a haematopoietic stem cell disorder, almost a...
Background : Chronic myelogenous leukemia (CML) is characterised by the t(9;22)(q34;q11.2) which res...
We describe the application of fluorescence in situ hybridization (FISH) in a case of suspected chro...
Abstract Background The t(9;22)(q34;q11), generating the Philadelphia (Ph) chromosome, is found in m...
The virtually obligatory presence of the Philadelphia chromosome may suggest a causal homogeneity, b...
Background/Aims: New molecular cytogenetic tech-niques are increasingly applied as a routine investi...
At diagnosis, about 5% of Chronic Myeloid Leukemia (CML) patients lacks Philadelphia chromosome (Ph)...
At diagnosis, about 5% of Chronic Myeloid Leukemia (CML) patients lacks Philadelphia chromosome (Ph)...
Chronic myelogenous leukemia (CML) in accelerated phase (AP-CML). Epidemiology Only one case to date...
Complex variant 9;22 translocations occur in a significant minority of chronic myelogenous leukaemia...